-
-
-
-
-
-
-
Marinus Pharmaceuticals to Present at Multiple Upcoming Investor Conferences
-
-
-
-
-
-
-
Marinus Pharmaceuticals (MRNS) R&D Day Provides Update on Ganaxolone’s Clinical Trials, PT to $9 at H.C. Wainwright
-
-
-
-
-
-
-
Marinus Pharmaceuticals Announces Pricing of $65 Million Public Offering of Common Stock and Concurrent Private Placement
-
-
-
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

